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Open radical cystectomy with variety of urinary diversions has remained the gold standard for the treatment of muscle invasive blad-
der cancer. This is a major surgical  procedure with significant post-operative morbidity and mortality. 
Over the last decade laparoscopy and robotics have made significant inroads into our surgical practice. The well known attractions of
minimally invasive surgery include reduced blood and tissue fluid loss during surgery, less post-operative pain, shorter hospital stay,
quicker return to work, cosmetically pleasing results and equivalent cancer control.
The difficulty in widespread adoption of these minimally invasive options are steep learning curves, limited facilities for training, in
the case of robotics formidable initial capital costs and cost of disposables. At present it may be fair to say that there is still a place
for open, laparoscopic and robotic radical cystectomy until we have made rigorous evaluation of the new minimally invasive surgi-
cal options. A review of our experience of minimally invasive radical cystectomy will be presented.
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INTRODUCTION
Bladder cancer is the fourth most common cancer in men
accounting for 5.5% of all cancer cases. Amongst women it is
the 8th most common cancer accounting for 2.3% of all cancers
(1). Bladder tumours exhibit a wide spectrum of biologic aggres-
siveness from benign behaving superficial low-grade papillary
neoplasms to highly malignant anaplastic carcinomas. 
Superficial bladder cancer represents nearly 75% of the bladder
tumours at first presentation. It comprises a hetero-genous group
of tumours that do not invade the muscularis propria. Majority of
these patients can be managed by transurethral resection with or
without intra-vesical chemo or immunotherapy. The overall 5
year survival rate of these patients is 70%- most patients dying
from non-bladder cancer causes (2).
A certain proportion of patients with superficial bladder cancer
progress to muscle invasion. High-grade T1 tumours (G3 pT1)
have 30-50% risk of progression (3). Likewise carcinoma in situ
(CIS) either alone or in association with papillary tumours have
potential to develop into a muscle invasive disease in 20-80% of
cases (4). About 25% patients with newly diagnosed bladder
cancer have muscle invasive disease at presentation and vast
majority of these are of poor histological differentiation.
Radical cystectomy remains the best therapy for invasive and
regional bladder cancer, high-risk superficial tumours resistant
to intra-vesical therapy, carcinoma-in-situ resistant to intra-vesi-
cal immuno or chemotherapy and recurrent multi-focal superfi-
cial disease refractory to repeat trans-urethral resection
with/without intra-vesical therapy. 
Open radical cystectomy (ORC) has been the standard of care.
Initial reports of laparoscopic radical cystectomy (LRC) started
emerging in 1995 with various forms of urinary diversions
including cutaneous (ileal conduit, ureterostomy), continent
(Mainz II) and orthotopic urinary diversions as alternatives to
open surgery. This was followed by reports of robotic radical
cystectomy (RRC) and a variety of urinary diversions.
Advantages of the minimally invasive radical cystectomy
(MIRC) include reduced blood and fluid loss, less post-operative
pain, shorter hospital stay, quicker return to normal activity, cos-
metically better outcome and equivalent cancer control in the
short-term. The main disadvantages of MIRC are the steep learn-
ing curve, longer operating times and higher costs. 
Open Radical Cystectomy (ORC)
Open radical cystectomy (ORC) has been the mainstay of surgi-
cal treatment for muscle invasive tumours and selected cases of
superficial bladder tumours as alluded to above. Many centres
around the world with interest in bladder cancer management
have performed thousands of these procedures with outcomes
published in the urological literature. Refinement of surgical
techniques, availability of ingenious devices like ligasure and
harmonic scalpel and improvements in post-operative surgical
care, have resulted in significant reduction in mortality and mor-
bidity. 
In spite of improvement in surgical techniques and reduction in
mortality and morbidity ORC remains one of the most major sur-
gical procedures performed by the urological surgeons. Even in
the best centres the major complication rate is around 5% and
minor complications occur in up to 30% patients. Open surgery
entails longer incisions and prolonged period of surgical retrac-
tion. This renders the incision quite painful and patients require
higher doses of opiates and other analgesics post-operatively.
Excessive bowel handling and opiates lead to prolonged ileus,
which is the most common complication after ORC. Prolonged
exposure of the bowel causes excessive fluid loss during surgery.
Blood loss during ORC remains high and approximately 25-50%
patients require blood transfusion. Longer incisions result in
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poor cosmetic result. Patients stay longer in the hospital. There
is considerable delay in return to normal activity with conse-
quent higher cost to the health care system and personal loss of
earnings(5, 6).
Optimum standards in terms of surgical outcomes and number of
cases per centre have been defined in ORC. The acceptable stan-
dards require no more than 10% positive surgical margins over-
all and 15% in patients with T3 & T4 tumours. The median num-
ber of lymph nodes removed should be 10-14. It is recommend-
ed that at least 10 cystectomies should be performed at any par-
ticular centre annually to maintain adequate levels of surgical
competence (7).
Three risk factors make radical bladder surgery more challeng-
ing. These include relatively old age of patients, higher inci-
dence of smoking related respiratory dysfunction and age relat-
ed co-morbidities. Thus besides the complexity and magnitude
of surgery higher prevalence of co-morbidities makes the man-
agement of this patient population quite challenging.
Laparoscopic Radical Cystectomy (LRC)
With increasing experience in laparoscopic surgery, urologists
around the world have attempted increasingly complex laparo-
scopic surgical procedures. Laparoscopic radical cystectomy
poses a unique surgical challenge, as it involves not only abla-
tion of the diseased bladder but in addition reconstruction of uri-
nary diversion. The latter part of the procedure is testing even for
the most experienced and skilled laparoscopic surgeons. 
Surgeons with different levels of surgical expertise have adopt-
ed three approaches to reconstruction. The most common is
extra-corporeal reconstruction either through a mini-laparotomy
or extension of one of the port sites. This incision also used for
delivering the specimen and lymph nodes. As the incision is
small and muscle splitting its morbidity is negligible. It does not
compromise the advantages of MIRC to any significant extent.
Others have used a combined approach whereby after extra-cor-
poreal reconstruction of the reservoir, it is returned into the
pelvic cavity and urethro-vesical anastomosis completed intra-
corporeally under direct vision. The least common approach is
complete intra-corporeal reconstruction and anastomosis. 
LRC has been evolving over the last decade. The first laparo-
scopic cystectomy was a simple cystectomy performed in 1992
for pyocystis on a paraplegic lady who previously had under-
gone ileal conduit urinary diversion for intractable urinary
incontinence (8). The procedure took 2 hours and 10 minutes.
There were no intra or post-operative complications and patient
was discharged after 5 days. 
The first LRC was reported in 1995 by Sanchez de Badajoz et al.
The patient was a 64 year old lady who had invasive bladder
cancer (9). Puppo et al, reported a series of LRC with trans-vagi-
nal delivery of specimens, in the same year. Ileal conduit in this
series was fashioned through a mini-laparotomy. Total operating
time ranged from 6-9 hours and hospital stay was 7-11 days (10).
Denewer et al reported (1999) a series 10 laparoscopic salvage
(post-radiation) radical cystectomies and uretero-sigmoidostomy
as urinary diversion through a mini-laparotomy. One of these
patients died due to uncontrolled reactionary haemorrhage.
Other complications included injury to the external iliac artery, a
urinary fistula, a pelvic collection and deep venous thrombosis
(11).
Kozminski & Partamiam (1999) were the first to report recon-
struction of an ileal conduit using combination of laparoscopic
and extra-corporeal approaches. Mobilization of the ureters and
transposition of the left ureter through the sigmoid mesocolon
was accomplished laparoscopically. Bowel and uretero-ileal
anastomoses were completed after extending the port site inci-
sions (12).
LRC and complete intra-corporeal construction of an ileal was
first reported by Gill et al in year 2000. (13,14). Turk et al (2001)
subsequently reported LRC and intra-corporeal construction of a
continent recto-sigmoid pouch in 5 patients (15). A further mile-
stone in MIRC and construction of intra-corporeal orthotopic
neo-bladder was achieved by Gill et al. (16). 
Most reports of LRC with ileal conduit urinary diversion do not
differ significantly with regard to the operating time and the type
and frequency of post-operative complications. The operating
time appears to be proportional to the experience of the surgeon.
In most series surgeons were at the early phase of the learning
curve with operating times usually in the range of 6-8 hours.
However, in a recent series  reported by Cathelineau et al the
median operating time was very respectable at 4 hours 20 min-
utes (17). In our experience the operating time reduces with
increasing experience and becomes equivalent to ORC. There-
fore this factor can no longer be considered as a disadvantage of
the LRC provided the operating surgeons have enough through
put to maintain and improve the operating skills. 
The longer operating times highlights the difficulties associated
with the learning curve of this complex surgical procedure and
in particular construction of urinary diversion. Although LRC
and continent urinary diversions and orthotopic reconstruction
of the bladder have been accomplished entirely intra-corporeal-
ly, operating times are fairly long. Therefore it is difficult to jus-
tify such a prolonged anaesthetic for the complete intra-corpore-
al approach.
Overall complication rate of LRC is around 12.6% with re-inter-
vention rate of 2.3%. In most laparoscopic series time to resump-
tion of oral intake ranges from 2-4 days and hospital stay 6-8
days. Gupta et al reported return to light work 4 weeks after a
LRC and urinary diversion (18). However, in our experience 6
weeks is a more realistic achievable goal. 
Our group has performed 38 radical cystectomies and ileal con-
duit urinary diversion using extra-corporeal approach through
extension of the port site. Operating time ranged from 230-390
minutes. Mean blood loss was 212 mls (50-1200mls). There
were no conversions. The number of lymph nodes harvested
ranged from 11-36. There was one positive surgical margin. All
patients made excellent recovery at 6 weeks.   
Basillote et al compared LRC and ileal neo-bladder constructed
through a 15 cm Pfannenstiel incision with ORC and ileal
neobladder. This was a retrospective analysis of the results. He
concluded, that laparoscopic assisted procedure is associated
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with decreased post-operative pain and quicker recovery (19).
Taylor et al reported a prospective non-randomized comparison
of hand assisted laparoscopic (HAL) cystectomy (n=8) and ORC
with ileal conduit diversion and concluded that HAL cystectomy
is associated with less blood loss, decreased post operative anal-
gesic requirements, quicker return of bowel function and shorter
length of hospital stay (20). 
Oncologic safety and effectiveness has been a concern of the
laparoscopic surgery in particular the risk of port site recurrence.
So far there are no reports of port site recurrences and surgical
margins have been reported clear in all cases of LRC. As most
surgeons have been operating on highly selected group of
patients, some critics attribute these results to better patient
selection. On the contrary proponents feel that better vision and
precision offered by the laparoscopy gives better results. 
Extended lymphadenectomy has been shown to have a positive
impact on the long-term outcome of the radical cystectomy (21).
One of the criticisms of laparoscopic cystetomy have been the
inadequacy of lymphadenectomy due its technical difficulties
and impact on the operating time. However, it is possible to
achieve an extended lymphadencetomy laparoscopically, though
this adds an additional hour to the operating time. There are two
series of LRC reporting survival rates of 85% and 65% at 3
years. In one series survival is comparable to ORC (22), but
other showing inferior results, attributed to poor histological dif-
ferentiation of the treated cases (23).
Robotic Radical Cystectomy (RRC)
There are certain inherent disadvantages of laparoscopic surgery.
These include relatively long instruments inserted through the
fixed entry points. There is an unnatural hand to eye co-ordina-
tion and often loss of eye-hand target axis during the procedure.
Visual depth perception is poor because of two-dimensional
view. Surgeon is dependent on the assistant to hold the camera
and hence the view of the surgical field is not under surgeon's
control. Most importantly surgical procedures like cystectomy
are physically demanding and result in considerable surgeon's
fatigue.
Robotic assistance allows hand to eye alignment, navigator cam-
era control and stereoscopic vision providing an open surgical
orientation. Other advantages include 7 degrees of freedom of
movement of the instruments, ambidextrous capability and elim-
ination of tremors. Da Vinci has open architecture and can allow
motion scaling. Thus benefits to the surgeon include improved
dexterity, enhanced visualisation, greater surgical precision,
increased range and intuitiveness of motion, improved access
and reduced fatigue. Hence robotic assistance translates open
surgery into minimally invasive surgery. The advent of robotic
surgery may be particularly useful in the construction of urinary
reservoirs. The main drawbacks of robotics are the costs of
implementation and lack of haptic feedback.
RRC and urinary diversion, was first reported by Menon et al in
2003 (24). Similar to LRC, it involves a six port trans-peritoneal
approach but focuses on the initial development of the recto-
vesical plane prior to transecting the recto-vesical pedicles. The
procedure was performed in three stages; firstly pelvic lym-
phadenectomy and cystoprostatectomy, secondly extracorporeal
formation of a neobladder and thirdly intra-corporeal urethro-
neovesical anastomosis following re-docking of the robot. The
operative times ranged from 260-310 minutes depending on
whether an ileal conduit or orthotopic neobladder was formed.
Blood loss was <150mls and margins were clear in all cases.
Two further case series of 1 and 2 patients were reported in the
same year. Beeken  et al described formation of a Hautmann
orthotopic neobladder intra-corporeally using a Da Vinci system
with an operating time of 8.5 hours and a blood loss of 200 ml.
(25). Balaji's group from Nebraska performed a robotic-assisted
totally intracorporeal laparoscopic ileal conduit urinary diver-
sion (26). The latter on 2 men and 1 woman had an operative
time of 630-830 minutes with a hospital stay of 5-10 days. They
highlighted the need for further operative refinement to reduce
rather lengthy operative time. The operative times for urinary
diversion ranged from 260-310 minutes depending on whether
an ileal conduit or orthotopic neobladder was formed. Blood loss
was <150mls and margins were clear in all cases.
The Guy's technique of RRC and ileal conduit diversion has
evolved from the Vattikuti RRC (24) and Eastbourne LRC (27).
A team of surgeons experienced in robotic, laparoscopic and
open radical cystectomy participate in each procedure. Posterior
and lateral dissections are performed first with anterior dissec-
tion and control of the dorsal venous plexus left to the end. Ileal
conduit formation is performed through a midline or appendix
incision. Blood loss is on average 150 ml with hospital stay of
11 days. There have been no deaths so far. Patients over 60 are
given prophylactic digoxin to prevent post-operative cardiac
arrythmias. All oncological margins are negative and at 1 year
follow-up no recurrences or metastases have occurred.
CONCLUSION
LRC and RRC offer the advantages of minimally invasive sur-
gery with better or at least equivalent outcomes in terms of can-
cer control. Operating times at present are expectedly long but
there is an obvious trend in improvement with increasing expe-
rience. In view of the complexity of the procedure, it is best per-
formed by a team of surgeons with advanced expertise in MIRC.
This will allow pooling of the cases in major centres, and short-
en the learning curve. Once long-term oncologic and functional
results become available, MIRC is likely to become the standard
of care in all age groups. Nerve and prostate sparing MIRC are
achievable and offer younger patients the possibility of main-
taining potency.
Having established the feasibility, safety and short-term effec-
tiveness of the MIRC, the time is right for randomised compar-
ative trials with ORC. The parameters to be compared should
include patient's age, co-morbidities/ASA grade, stage and grade
of the tumour, extent of lymph-adenectomy and number of
lymph nodes retrieved, operating time, blood loss, need for
transfusion intra or post-operatively, analgesic requirement (opi-
ates and non-opiates), length of paralytic ileus, time to mobilisa-
tion, hospital stay, time to return to normal activity, health relat-
ed quality of life (HRQL) assessment using standard instru-
ments, minor and major complications, costs of treatment and
follow up of up to 5 years. Until such trial data are available it
would be fair to say that there is still a place for open, laparo-
scopic and robotic radical cystectomy.
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Abbreviations (TABLE 1): IC: Ileal Conduit, MU: modified ureterosigmoidostomy, OIN: Orthotopic Ileal neobladder, IP: Indiana
Pouch, CU: Cutaneous urostomy, US: Ureterosigmoidostomy, HA: hand-assisted, PE: pulmonary embolism, DVT: Deep vein throm-
bosis, NS: not stated
Skraæenice ( TABLICA 1.):  IC: ilealni conduit: MU: modificirana ureterosigmoidostomija, OIN: ortotopièni ilealni neomjehur, IP:
Indiana Pouch, CU: kutana urostomija, US: ureterosigmoidostomija, HA: ruèno potpomognut/a, PE: pluæna embolija, DVT: duboka
venska tromboza, NS: nije navedeno
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2 x pouch leakage/curenje iz pouch-a 
2 x bowel obstruction/opstrukcija 
crijeva 
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1 x pelvic infection/1 x zdjelièna 
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PRIJETI LI "IZUMIRANJE" OTVORENOJ RADIKALNOJ CISTEKTOMIJI?
Mohammad Shamim Khan1,  Peter  Rimington2, Prokar Dasgupta1
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SAŽETAK
Otvorena radikalna cistektomija sa svim pridruženim oblicima derivacije urina je zlatni standard u lijeèenju invazivnog raka
mokraænog mjehura. Radikalna cistektomija je opsežna operacija sa znaèajnim poslijeoperacijskim morbiditetom i smrtnošæu.
Tijekom proteklog desetljeæa, laparoskopija i robotika znaèajno prodiru u svakodnevnu kiruršku praksu. Opæenito prihvaæene pred-
nosti minimalno invazivne kirurgije ukljuèuju smanjeni operativni gubitak krvi i tjelesnih tekuæina, slabiju poslijeoperacijsku bol,
kraæi bolnièki boravak, brži povratak radnim aktivnostima, estetski ugodne rezultate i zadovoljavajuæu kontrolu maligne bolesti.
Poteškoæe u širem prihvaæanju minimalno invazivnih operacija jesu strma krivulja uèenja, ogranièen broj centara za edukaciju, a u
sluèaju robotski potpomognute kirurgije veliki poèetni trošak i trošak potrošnih materijala. Za sada u našoj svakodnevnici ima mjes-
ta za otvorenu, laparaskopsku i robotski potpomognutu  radikalnu cistektomiju, sve dok se ne uèini temeljita procjena i usporedba
novih minimalno invazivnih kirurških opcija. Prikazat æemo pregled naših iskustava u minimalno invazivnoj radikalnoj cistektomiji. 
Kljuène rijeèi: laparoskopska radikalna cistektomija, radikalna cistektomija, radikalna cistektomija potpomognuta robotikom 
